Superoxide dismutase and cytokines in chronic patients with schizophrenia: Association with psychopathology and response to antipsychotics

Psychopharmacology

Volumn 204, Issue 1, 2009, Pages 177-184

  Zhang, Xiang Yang ^a,c   Zhou, Dong Feng ^b   Qi, Ling Yan ^c   Chen, Song ^c   Cao, Lian Yuan ^c   Chen, Da Chun ^c   Xiu, Mei Hong ^c   Wang, Fan ^c   Wu, Gui Ying ^a   Lu, Lin ^d   Kosten, Therese A ^a   Kosten, Thomas R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^c BEIJING HUILONGGUAN HOSPITAL   (China)

^d PEKING UNIVERSITY   (China)

Author keywords

Antioxidant enzymes; Antipsychotic; Cytokine; Immune; Oxidative stress; Psychopathology; Schizophrenia

Indexed keywords

CYTOKINE; HALOPERIDOL; INTERLEUKIN 2; INTERLEUKIN 6; NEUROLEPTIC AGENT; RISPERIDONE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OXIDATIVE STRESS; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISPERIDONE; SCHIZOPHRENIA; SEX FACTORS; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME;

EID: 67349221465     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1447-6     Document Type: Article

References (55)

1. V Arolt M Rothermundt KP Wandinger H Kirchner 2000 Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment Mol Psychiatry 5 150 158 (Pubitemid 30229429)
2. PA Baeuerle RA Rupec HL Pahl 1996 Reactive oxygen intermediates as second messengers of a general pathogen response Pathol Biol 44 29 35 (Pubitemid 26088475)
3. H Bessler Z Levental L Karp I Modai M Djaldetti A Weizman 1995 Cytokine production in drug-free and neuroleptic-treated schizophrenic patients Biol Psychiatry 38 297 302
4. A Bleich SL Brown R Kahn HM van Praag 1988 The role of serotonin in schizophrenia Schizophr Bull 14 297 315 (Pubitemid 18216019)
5. CL Cazzullo E Sacchetti A Galluzzo A Panariello F Colombo A Zagliani M Clerici 2001 Cytokine profiles in drugnaive schizophrenic patients Schizophr Res 47 293 298 (Pubitemid 32244114)
6. W Dröge HP Eck H Gmünder S Mihm 1991 Requirement for prooxidant and antioxidant states in T cell mediated immune responses. Relevance for the pathogenetic mechanisms of AIDS? Klin Wochenschr 15 69 1118 1122
7. W Dröge HP Eck S Mihm 1994 Oxidant-antioxidant status in human immunodeficiency virus infection Methods Enzymol 233 594 601 (Pubitemid 24177582)
8. EM Eugui B DeLustro S Rouhafza M Ilnicka SW Lee R Wilhelm AC Allison 1994 Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells Int Immunol 6 409 422 (Pubitemid 24087234)
9. C Gabay I Kushner 1999 Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 448 454 (Pubitemid 29084777)
10. R Ganguli Z Yang G Shurin RKN Chengappa JS Brar AV Gubbi BS Rabin 1994 Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness Psychiatry Res 51 1 10
11. R Ganguli JS Brar KNR Chengappa M Deleo ZW Yang G Shurin 1995 Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients Arch Gen Psychiatry 52 668 672
12. H Herken E Uz H Ozyurt S Sogut O Virit O Akyol 2001 Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia Mol Psychiatry 6 66 73 (Pubitemid 32096067)
13. DF Horrobin MS Manku H Hillman A Iain M Glen 1991 Fatty acid levels in the brains of schizophrenics and normal controls Biol Psychiatry 30 795 805
14. PA Janssen CJ Niemegeers F Awouters KH Schellekens AA Megens TF Meert 1988 Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties J Pharmacol Exp Ther 244 685 693 (Pubitemid 18076615)
15. YK Kim L Kim MS Lee 2000 Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics Schizophr Res 44 165 175 (Pubitemid 30657953)
16. Z Kronfol DG Remick 2000 Cytokines and the brain: implications for clinical psychiatry Am J Psychiatry 157 683 694 (Pubitemid 30249643)
17. PA Lapchak 1992 A role of interleukin-2 in the regulation of striatal dopamingergic function NeuroReport 3 165 168
18. J Licinio JP Seibyl M Altemus DS Charney JH Krystal 1993 Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients Am J Psychiatry 150 1408 1410 (Pubitemid 23259579)
19. A Lin G Kenis S Bignotti GJ Tura R DeJong E Bosmans R Pioli C Altamura S Scharpe M Maes 1998 The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 Schizophr Res 32 9 15 (Pubitemid 28338119)
20. JB Lohr 1991 Oxygen radicals and neuropsychiatric illness. Some speculations Arch Gen Psychiatry 48 1097 1106
21. JK Lohr K Flynn 1992 Smoking and schizophrenia Schizophr Res 8 93 102
22. JB Lohr JA Browning 1995 Free radical involvement in neuropsychiatric illnesses Psychopharmacol Bull 31 159 165
23. JB Lohr S Underhill S Moir DV Jeste 1990 Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia Biol Psychiatry 28 535 539 (Pubitemid 20298448)
24. M Maes E Bosmans J Calabrese R Smith H Meltzer 1995 Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stablizers J Psychiatr Res 29 141 152
25. M Maes E Bosmans G Kenis R De Jong RS Smith HY Meltzer 1997 In vivo immunomodulatory effects of clozapine in schizophrenia Schizophr Res 26 221 225 (Pubitemid 27431787)
26. M Maes L Bocchio Chiavetto S Bignotti G Battisa Tura R Pioli F Boin G Kenis E Bosmans R de Jongh A Lin G Racagni CA Altamura 2000 Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics Eur Neuropsychopharmacol 10 119 124 (Pubitemid 30120041)
27. CG [tmp] McAllister DP van Kammen TJ Rehn AL Miller J Gurklis ME Kelley J Yao JL Peters 1995 Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status Am J Psychiatry 159 1291 1297
28. SP Mahadik S Mukherjee 1996 Free radical pathology and antioxidant defense in schizophrenia: a review Schizophr Res 19 1 17 (Pubitemid 26133208)
29. SP Mahadik S Mukherjee EE Correnti R Scheffer J Mahadik 1998 Elevated plasma lipid peroxides at the onset of nonaffective psychosis Biol Psychiatry 43 674 679 (Pubitemid 28222388)
30. RG [tmp] McCreadie E Macdonald D Wiles G Campbell JR Pateson 1995 The Nithsdale Schizophrenia Surveys XIV: plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia and in normal subjects Br J Psychiatry 167 1 8 (Pubitemid 26197770)
31. S Mukherjee SP Mahadik R Scheefer EE Correnti H Kelkar 1996 Impaired antioxidant defense at the onset of psychosis Schizophr Res 19 19 26 (Pubitemid 26133209)
32. N Muller M Reidel M Ackenheil MJ Schwarz 1999 The role of immune function in schizophrenia: an overview Eur Arch Psychiatry Clin Neurosci 249 suppl. 4 62 68 (Pubitemid 30011754)
33. M Peet J Laugharne N Rangarajan D Horrobin G Reynolds 1995 Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients J Psychiatr Res 29 227 232 (Pubitemid 26176458)
34. M Peet JD Laugharne J Mellor CN Ramchand 1996 Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation Prostaglandins Leukot Essent Fatty Acids 55 71 75 (Pubitemid 26321121)
35. T Pollmächer D Hinze-Selch T Fenzel T Kraus A Schuld J Mullington 1997 Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol Am J Psychiatry 154 1763 1765 (Pubitemid 27516599)
36. AM Ponizovsky I Modai Y Nechamkin G Barshtein MS Ritsner S Yedgar S Lecht LD Bergelson 2001 Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology Schizophr Res 52 121 126 (Pubitemid 32947055)
37. RD Reddy JK Yao 1996 Free radical pathology in schizophrenia: a review Prostaglandins Leukot Essent Fatty Acids 55 33 43 (Pubitemid 26321116)
38. RD Reddy MP Sahebarao S Mukherjee JN Murthy 1991 Enzymes of the antioxidant defense system in chronic schizophrenic patients Biol Psychiatry 30 409 412
39. JM Reimund AC Allison CD Muller S Dumont JS Kenney R Baumann B Duclos P Poindron 1998 Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis Eur J Clin Invest 28 145 150 (Pubitemid 28085815)
40. A Schotte PF Janssen W Gommeren WH Luyten P Van Gompel AS Lesage K De Loore JE Leysen 1996 Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology 124 57 73 (Pubitemid 26112775)
41. R Schreck P Rieber PA Baeuerle 1991 Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J 10 2247 2258
42. R Schreck K Albermann PA Baeuerle 1992 Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review) Free Radic Res Commun 17 221 237 (Pubitemid 23207431)
43. P Seeman 1987 Dopamine receptors and the dopamine hypothesis of schizophrenia Synapse 1 133 152 (Pubitemid 17119661)
44. C Song A Lin G Kenis E Bosmans M Maes 2000 Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist Schizophr Res 42 157 164 (Pubitemid 30163081)
45. DP van Kammen CG [tmp] McAllister-Sistilli ME Kelley JA Gurklis JK Yao 1999 Elevated interleukin-6 in schizophrenia Psychiatry Res 87 129 136 (Pubitemid 29494972)
46. JK Yao DP van Kammen J Gurklis 1994 Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures Schizophr Res 13 227 232 (Pubitemid 24302652)
47. JK Yao R Reddy LG [tmp] McElhinny DP van Kammen 1998 Effects of haloperidol on antioxidant defense system enzymes in schizophrenia J Psychiatr Res 32 385 391 (Pubitemid 28491244)
48. JK Yao RD Reddy DP van Kammen 2000 Abnormal age related changes of plasma antioxidant proteins in schizophrenia Psychiatry Res 97 137 151 (Pubitemid 32126553)
49. JK Yao RD Reddy DP van Kammen 2001 Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications CNS Drugs 15 287 310 (Pubitemid 32337052)
50. JK Yao CG Sistilli DP van Kammen 2003 Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia Prostaglandins Leukot Essent Fatty Acids 69 429 436 (Pubitemid 37464053)
51. S Zalcman JM Green-Johnson L Murray DM Nancy D Dyck H Anisman AJ Greenberg 1994 Cytokine-specific central monoamine alterations induced by interleukin-1, 2, and 6 Brain Res 643 40 49 (Pubitemid 24115074)
52. XY Zhang DF Zhou LY Cao PY Zhang GY Wu YC Shen 2001 Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study Int Clin Psychopharmacol 16 325 330
53. XY Zhang DF Zhou PY Zhang GY Wu LY Cao YC Shen 2002 Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology Schizophr Res 57 247 258 (Pubitemid 35240027)
54. XY Zhang DF Zhou LY Cao PY Zhang GY Wu 2003 Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms Psychiatry Res 117 85 88 (Pubitemid 36173777)
55. XY Zhang DF Zhou LY Cao DC Chen FY Zhu GY Wu 2003 Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements Schizophr Res 62 245 250 (Pubitemid 36773933)